Stephen I. Pelton, MD
Professor
Boston University School of Medicine
Dept of Pediatrics
Infectious Diseases

MD, State University of New York at Buffalo



Stephen I Pelton MD is Professor of Pediatrics and Epidemiology at Boston University School of Medicine and Public Health and Director of Pediatrics Infectious Diseases at Boston Medical Center. Dr Pelton's interests focus on the effects of recurrent disease and the long term effects of HIV, Hepatitis C and B, and Herpes among other things. Additionally, he organizes numerous clinical trials to discover new approaches to HIV prevention and treatment.

Director (Section) of Pediatrics>Infectious Disease
Boston University School of Medicine
Pediatrics
Infectious Diseases

Professor
Boston University School of Public Health
Epidemiology


Active Staff Privileges
Boston Medical Center
Pediatrics




ACUTE OTITIS MEDIA (AOM) STUDY
08/01/2015 - 12/31/2018 (PI)
Pfizer, Inc.

PROPOSAL TO EVALUATE PREVALENCE, SEROTYPE DISTRIBUTION AND DENSITY OF PNEUMOCOCCAL NASOPHARYNGEAL COLONIZATION IN CHILDREN AND PARENTS
12/15/2015 - 09/30/2017 (PI)
Pfizer, Inc.

DEFINING THE NEW EQUILIBRIUM OF PNEUMOCOCCAL NASOPHARYNGEAL COLONIZATION FOLLOWING INTRODUCTION OF PCV13
01/01/2013 - 06/30/2017 (PI)
Merck, Sharp & Dohme Corp

ENHANCED SURVEILLANCE FOR IPD IN MASSACHUSETTS CHILDREN
01/01/2007 - 06/30/2017 (PI)
Wyeth Pharmaceuticals

CONTINUED SURVEILLANCE OF IPD IN CHILDREN LESS THAN 18 YEARS OLD IN MASSACHUSETTS IN 2010-2012 (IMPACT OF THE INTRODUCTION OF PCV13)
11/15/2010 - 11/14/2013 (PI)
Pfizer, Inc.

CARRIAGE PREVALENCE OF NTHI IN MOTHER AND INFANT DYADS
11/01/2008 - 07/22/2011 (PI)
GlaxoSmithKline, Inc.

Pedi ID Fellow: International Fellowship in Vaccine Preventable Diseases
05/01/2008 - 04/30/2010 (PI)
Wyeth Pharmaceuticals

Enhanced Surveillance for Meningococcal Disease
04/07/2005 - 04/06/2008 (PI)
Sanofi-Pasteur, SA

NTHi LPS: Virulence Factor and Vaccine Candidate
08/01/2003 - 07/31/2007 (Co-PI)
NIH/National Institute on Deafness & Communication Disorders
5 R01 DC05855 03

Identification of Children with Invasive Pneumococcal Disease in Massachusetts and Immunologic Evaluation of Vaccine Failures
10/01/2001 - 06/30/2005 (PI)
Wyeth-Lederle

Showing 10 of 20 results. Show All Results

Pneumonia Biology
01/11/2017 - 12/31/2023 (PI)
Trustees of Boston University NIH-NHLBI

IMPAACT 2014: Phase I/II Study of the Pharmacokinetics, Safety and Tolerability of Doravirine…
03/01/2018 - 07/31/2021 (PI)
Johns Hopkins University Merck

Trans-tympanic delivery of antibiotics
07/22/2016 - 06/30/2021 (PI)
Children's Hospital NIH-NIDCD
5R01DC015050-03

Prevention Of Non-BPP
03/01/2000 - 06/30/2019 (PI)
Shereta Seelig Trus

Interactions of Streptococcus pneumoniae and Non-typeable Haemophilus influenzae and the developm…
10/01/2017 - 04/30/2019 (PI)
Merck

RWMCM Part A - Ryan White Medical Case Management
07/01/2016 - 02/28/2019 (PI)
PHC HRSA

Ryan White Medical Transportation
07/01/2016 - 02/28/2019 (PI)
PHC HRSA

Surveillance for Invasive Pneumococcal Disease (IPD) and Serotype Replacement in the Ten Years follo
05/15/2009 - 12/31/2018 (PI)
Kaiser Foundation Research Inst Wyeth Pharmaceutical

LOC-IMPAACT Leadership Group - Core Protocol Funds
12/01/2017 - 11/30/2018 (PI)
Johns Hopkins University NIH-NICHD
5UM1AI068632-12

LOC-IMPAACT Leadership Group - Protocol IMPAACT 2018
12/01/2017 - 11/30/2018 (PI)
Johns Hopkins University NIH-NICHD

Showing 10 of 56 results. Show All Results


Yr Title Project-Sub Proj Pubs
2016 Single Antigen Strategy for Prevention of Recurrent and Chronic Suppurative Otitis 5R21DC014323-02
2015 Single Antigen Strategy for Prevention of Recurrent and Chronic Suppurative Otitis 1R21DC014323-01A1
2007 RANDOMIZED TRIAL OF THE SAFETY AND IMMUNOGENICITY OF FLUMIST IN HIV INF CHILDREN 2M01RR000533-39-8164 429
2007 SAFETY AND IMMUNOGENICITY STUDY OF QUADRIVALENT HUMAN PAPILLOMAVIRUS 2M01RR000533-39-8202 429
2007 LATE OUTCOMES OF PEDIATRIC HIV INFECTION (PACTG 219C VERSION 40) 2M01RR000533-39-8205 429
2006 RANDOMIZED TRIAL OF THE SAFETY AND IMMUNOGENICITY OF FLUMIST IN HIV INF CHILDREN 5M01RR000533-38-5614 429
2006 IMMUNOGENICITY OF LIVE ATTENUATED VARICELLA VACCINE HIV INFECTED CHILDREN 5M01RR000533-38-5632 429
2006 LATE OUTCOMES OF PEDIATRIC HIV INFECTION (PACTG 219C VERSION 40) 5M01RR000533-38-5633 429
2006 ULTRASOUND EVAL OF FLOW RELATED ARTERIAL DILATION IN HIV INFECTED CHILDREN 5M01RR000533-38-5588 429
2005 ULTRASOUND EVAL OF FLOW RELATED ARTERIAL DILATION IN HIV INFECTED CHILDREN 5M01RR000533-37-5428 429
Showing 10 of 45 results. Show All Results
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Dagan R, Pelton S, Bakaletz L, Cohen R. First Otitis Media and Pneumococcal Conjugate Vaccine Serotypes in Infants. Pediatr Infect Dis J. 2018 Dec; 37(12):e351-e352. PMID: 30408013.
     
  2. Sings HL, De Wals P, Gessner BD, Isturiz R, Laferriere C, McLaughlin JM, Pelton S, Schmitt HJ, Suaya JA, Jodar L. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-Analysis of Observational Studies. Clin Infect Dis. 2018 Oct 23. PMID: 30357326.
     
  3. Yang R, Sabharwal V, Shlykova N, Okonkwo OS, Pelton SI, Kohane DS. Treatment of Streptococcus pneumoniae otitis media in a chinchilla model by transtympanic delivery of antibiotics. JCI Insight. 2018 Oct 04; 3(19).View Related Profiles. PMID: 30282835.
     
  4. Yildirim I, Pelton SI. Infants at risk for Invasive Pneumococcal Disease in the PCV13 Era. Clin Infect Dis. 2018 Oct 03. PMID: 30281070.
     
  5. Pelton SI, Bornheimer R, Doroff R, Shea KM, Sato R, Weycker D. Decline in Pneumococcal Disease Attenuated in Older Adults and Those with Comorbidities Following Universal Childhood PCV13 Immunization. Clin Infect Dis. 2018 Sep 20. PMID: 30239637.
     
  6. Mrkvan T, Pelton SI, Ruiz-Guiñazú J, Palmu AA, Borys D. Effectiveness and impact of the 10-valent pneumococcal conjugate vaccine, PHiD-CV: review of clinical trials and post-marketing experience. Expert Rev Vaccines. 2018 Sep; 17(9):797-818. PMID: 30185083.
     
  7. Rijkers GT, Pelton SI. The old man's friend. Pneumonia (Nathan). 2018; 10:8. PMID: 30062083.
     
  8. Balsells E, Dagan R, Yildirim I, Gounder PP, Steens A, Muñoz-Almagro C, Mameli C, Kandasamy R, Givon Lavi N, Daprai L, van der Ende A, Trzcinski K, Nzenze SA, Meiring S, Foster D, Bulkow LR, Rudolph K, Valero-Rello A, Ducker S, Vestrheim DF, von Gottberg A, Pelton SI, Zuccotti G, Pollard AJ, Sanders EAM, Campbell H, Madhi SA, Nair H, Kyaw MH. The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: A systematic review and meta-analysis. J Infect. 2018 Nov; 77(5):368-378. PMID: 29964140.
     
  9. Pelton SI. Deconstructing Pneumococcal Progression from Colonization to Disease. Infect Immun. 2018 Jun; 86(6). PMID: 29610253.
     
  10. Bornheimer R, Shea KM, Sato R, Weycker D, Pelton SI. Risk of exacerbation following pneumonia in adults with heart failure or chronic obstructive pulmonary disease. PLoS One. 2017; 12(10):e0184877.View Related Profiles. PMID: 29028810.
     
Showing 10 of 271 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 260 publications over 36 distinct years, with a maximum of 15 publications in 2010

YearPublications
19803
19813
19832
19842
19855
19885
19894
19903
19913
19925
19937
19944
19957
19963
19972
19984
199911
200011
20014
200211
20039
20044
200511
20066
20077
20089
200914
201015
201112
201213
201312
201414
20159
20166
201711
20189
Contact for Mentoring:


670 Albany St Biosquare III
Boston MA 02118
Google Map


Pelton's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department